Biovail Corp News - BVF | Aktien New York Börse

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Valeant and Biovail Announce Results of Special Meetings of Shareholders

Valeant Pharmaceuticals International (NYSE: VRX) and Biovail Corporation (NYSE/TSX: BVF) announced that at today’s Special...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT...

Standard & Poor's Announces Changes to U.S. Indices

Standard & Poor's Announces Changes to U.S. Indices PR Newswire NEW YORK, Sept. 22 NEW YORK, Sept. 22 /PRNewswire/ -- S&P SmallCap 600...

Valeant & Biovail Announce Valeant’s Intention to Declare a Special Dividend to Valeant Stockholders upon Obtaining Shareho...

Valeant Pharmaceuticals International (NYSE: VRX) and Biovail Corporation (NYSE/TSX: BVF) today announced that Valeant currently...

Valeant Announces Pricing of Senior Notes

Valeant Announces Pricing of Senior Notes PR Newswire ALISO VIEJO, Calif., Sept. 22 ALISO VIEJO, Calif., Sept. 22 /PRNewswire-FirstCall/...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The...

Valeant Plans Senior Notes Offering and Begins Arrangement of New Credit Facilities

Valeant Plans Senior Notes Offering and Begins Arrangement of New Credit Facilities PR Newswire ALISO VIEJO, Calif., Sept. 9 ALISO VIEJO, Calif...

- Current report filing (8-K)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The...

- Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...

- Registration Statement for securities to be issued in business combination transactions (S-4/A)

Table of Contents As filed with the U.S. Securities and Exchange Commission on August 18, 2010...

Valeant and Biovail Set Date for Shareholders Meetings

Valeant Pharmaceuticals International (NYSE: VRX) and Biovail Corporation (NYSE/TSX: BVF) today announced that both companies...

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Registrieren Sie sich für ein Konto unter ADVFN

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Biovail Corp (BVF)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

BVF Nachrichten

Valeant and Biovail Announce Results of Special Meetings of Shareholders

- Current report filing (8-K)

Standard & Poor's Announces Changes to U.S. Indices

Valeant & Biovail Announce Valeant’s Intention to Declare a Special Dividend to Valeant Stockholders upon Obtaining Shareho...

Valeant Announces Pricing of Senior Notes

- Current report filing (8-K)

- Current report filing (8-K)

Valeant Plans Senior Notes Offering and Begins Arrangement of New Credit Facilities

- Current report filing (8-K)

- Statement of Changes in Beneficial Ownership (4)

- Registration Statement for securities to be issued in business combination transactions (S-4/A)

Valeant and Biovail Set Date for Shareholders Meetings

BVF Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Biovail Corp (BVF) News

Biovail Corp (BVF)

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

BVF Nachrichten

Valeant and Biovail Announce Results of Special Meetings of Shareholders

- Current report filing (8-K)

Standard & Poor's Announces Changes to U.S. Indices

Valeant & Biovail Announce Valeant’s Intention to Declare a Special Dividend to Valeant Stockholders upon Obtaining Shareho...

Valeant Announces Pricing of Senior Notes

- Current report filing (8-K)

- Current report filing (8-K)

Valeant Plans Senior Notes Offering and Begins Arrangement of New Credit Facilities

- Current report filing (8-K)

- Statement of Changes in Beneficial Ownership (4)

- Registration Statement for securities to be issued in business combination transactions (S-4/A)

Valeant and Biovail Set Date for Shareholders Meetings

BVF Finanzen

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Registrieren Sie sich für ein Konto unter ADVFN

Werbung entfernen